Sage Therapeutics’ (SAGE) “Hold” Rating Reiterated at Needham & Company LLC
Needham & Company LLC reiterated their hold rating on shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) in a research report report published on Wednesday,Benzinga reports. Other equities research analysts also recently issued research reports about the company. TD Cowen lowered their price target on Sage Therapeutics from $10.00 to $9.00 and set a “hold” […]
Needham & Company LLC reiterated their hold rating on shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) in a research report report published on Wednesday,Benzinga reports. Other equities research analysts also recently issued research reports about the company. TD Cowen lowered their price target on Sage Therapeutics from $10.00 to $9.00 and set a “hold” […]
